Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia
- PMID: 25164323
- PMCID: PMC4214881
- DOI: 10.1002/ana.24262
Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia
Abstract
Objective: Pneumonia is a morbid complication of stroke, but evidence-based strategies for its prevention are lacking. Acid-suppressive medications have been associated with increased risk for nosocomial pneumonia in hospitalized patients. It is unclear whether these results can be extrapolated to stroke patients, where other factors strongly modulate pneumonia risk. We investigated the association between acid-suppressive medication and hospital-acquired pneumonia in patients with acute stroke.
Methods: All patients hospitalized with acute ischemic stroke or intracerebral hemorrhage in a large, urban academic medical center in Boston, Massachusetts from June 2000 to June 2010 who were ≥18 years of age and hospitalized for ≥2 days were eligible for inclusion. Acid-suppressive medication use was defined as any pharmacy charge for a proton-pump inhibitor or histamine-2 receptor antagonist. Multivariate logistic regression was used to control for confounders. The main outcome measure was hospital-acquired pneumonia, defined via International Classification of Diseases, Ninth Revision, Clinical Modification codes.
Results: The cohort comprised 1,676 admissions. Acid-suppressive medication was ordered in 1,340 (80%) and hospital-acquired pneumonia occurred in 289 (17.2%). The unadjusted incidence of hospital-acquired pneumonia was higher in the group exposed to acid-suppressive medication compared to those unexposed (20.7% vs 3.6%, odds ratio [OR] = 7.0, 95% confidence interval [CI] = 3.9-12.7). After adjustment, the OR of hospital-acquired pneumonia in the exposed group was 2.3 (95% CI = 1.2-4.6). The association was significant for proton-pump inhibitors (OR = 2.7, 95% CI = 1.4-5.4), but not for histamine-2 receptor antagonists (OR = 1.6, 95% CI = 0.8-3.4).
Interpretation: In this large hospital-based cohort of patients presenting with acute stroke, acid-suppressive medication use was associated with increased odds of hospital-acquired pneumonia.
© 2014 American Neurological Association.
Conflict of interest statement
Conflicts of Interest/Disclosure Statement: None of the authors have any conflicts of interest.
Similar articles
-
Acid-suppressive medication use and the risk for hospital-acquired pneumonia.JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722. JAMA. 2009. PMID: 19470989
-
Risk of Stroke-Associated Pneumonia and Oral Hygiene.Cerebrovasc Dis. 2016;41(1-2):35-9. doi: 10.1159/000440733. Epub 2015 Nov 20. Cerebrovasc Dis. 2016. PMID: 26584429
-
Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding.Arch Intern Med. 2011 Jun 13;171(11):991-7. doi: 10.1001/archinternmed.2011.14. Epub 2011 Feb 14. Arch Intern Med. 2011. PMID: 21321285 Free PMC article.
-
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.CMAJ. 2011 Feb 22;183(3):310-9. doi: 10.1503/cmaj.092129. Epub 2010 Dec 20. CMAJ. 2011. PMID: 21173070 Free PMC article. Review.
-
Proton pump inhibitors: bacterial pneumonia.Prescrire Int. 2012 Sep;21(130):210-2. Prescrire Int. 2012. PMID: 23016253 Review.
Cited by
-
Post-Stroke Infections: Insights from Big Data Using Clinical Data Warehouse (CDW).Antibiotics (Basel). 2023 Apr 12;12(4):740. doi: 10.3390/antibiotics12040740. Antibiotics (Basel). 2023. PMID: 37107102 Free PMC article.
-
Risk of Post-Myocardial Infarction Pneumonia with Proton Pump Inhibitors, H2 Receptor Antagonists and Mucoprotective Agents: A Retrospective Nationwide Cohort Study.J Pers Med. 2022 Jan 9;12(1):78. doi: 10.3390/jpm12010078. J Pers Med. 2022. PMID: 35055393 Free PMC article.
-
Stroke and Pneumonia: Mechanisms, Risk Factors, Management, and Prevention.Cureus. 2021 Nov 26;13(11):e19912. doi: 10.7759/cureus.19912. eCollection 2021 Nov. Cureus. 2021. PMID: 34984111 Free PMC article. Review.
-
A Retrospective Cohort Analysis of the Use of Enteral Nutrition Plus Pharmacologic Prophylaxis or Enteral Nutrition Alone.Hosp Pharm. 2021 Dec;56(6):729-736. doi: 10.1177/0018578720954159. Epub 2020 Sep 10. Hosp Pharm. 2021. PMID: 34732931 Free PMC article.
-
Stroke-Associated Pneumonia: Management Issues.J Neurosci Rural Pract. 2019 Jul;10(3):472-473. doi: 10.1055/s-0039-1696743. Epub 2019 Oct 7. J Neurosci Rural Pract. 2019. PMID: 31599270 Free PMC article. No abstract available.
References
-
- Koennecke HC, Belz W, Berfelde D, et al. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011 Sep 6;77(10):965–972. - PubMed
-
- Hannawi Y, Hannawi B, Rao CP, Suarez JI, Bershad EM. Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis. 2013;35(5):430–443. - PubMed
-
- Kasuya Y, Hargett JL, Lenhardt R, et al. Ventilator-associated pneumonia in critically ill stroke patients: frequency, risk factors, and outcomes. J Crit Care. 2011 Jun;26(3):273–279. - PubMed
-
- Vermeij FH, Scholte op Reimer WJ, de Man P, et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27(5):465–471. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
